First-Line Contraceptive Methods for Pregnancy Prevention
Long-acting reversible contraception (LARC)—specifically contraceptive implants and intrauterine devices (IUDs)—should be recommended as first-line contraceptive methods for sexually active reproductive-age individuals seeking pregnancy prevention. 1, 2
Why LARC Methods Are First-Line
LARC methods are the most effective reversible contraceptives available, with failure rates of less than 1% per year in typical use 1, 3. This superior effectiveness stems from their independence from user adherence—once placed, they work continuously without requiring daily action from the patient.
Specific LARC Options in Order of Effectiveness:
Contraceptive Implant (Nexplanon/Implanon):
- Failure rate: 0.05% per year 2, 4
- Duration: 3 years
- Single-rod subdermal device containing etonogestrel
- Highest continuation rate at 1 year: 84% 1, 2
- Can be inserted immediately postpartum, even before hospital discharge 1
Levonorgestrel IUD:
- Failure rate: 0.2% per year 2, 4
- Duration: varies by formulation (3-8 years depending on device)
- Continuation rate: 80% at 1 year 1, 2
Copper IUD:
- Failure rate: 0.8% per year 2, 4
- Duration: up to 10-12 years
- Continuation rate: 78% at 1 year 1, 2
- Non-hormonal option for those who prefer to avoid hormones
Counseling Approach: Most Effective First
Pediatricians and healthcare providers are explicitly encouraged to counsel patients in order from most to least effective, discussing LARC methods first 1. This tiered counseling approach prioritizes methods that minimize pregnancy risk—the primary outcome affecting morbidity and mortality in reproductive-age individuals.
Key Counseling Points:
- LARC methods are appropriate for all women, including adolescents and nulliparous women 2
- No examinations are needed before implant insertion 5
- IUDs require only bimanual examination and cervical inspection 5
- Same-day initiation is possible if reasonably certain the patient is not pregnant 5
Second-Tier Options
If LARC methods are declined or contraindicated, the next tier includes:
Injectable DMPA (Depo-Provera):
- Failure rate: 6% typical use, 0.2% perfect use 2, 4
- Continuation rate: 56% at 1 year 2
- Requires injection every 3 months
Combined Hormonal Contraceptives (pills, patch, ring):
- Failure rate: 9% typical use, 0.3% perfect use 2, 4
- Continuation rate: 67% at 1 year 2
- Effectiveness heavily dependent on consistent daily/weekly use
- The wide gap between typical and perfect use (9% vs 0.3%) reflects the critical role of user adherence 2
Critical Pitfall to Avoid
Do not default to oral contraceptive pills simply because they are most commonly prescribed. While pills comprise 21.9% of contraceptive use in the US 3, their typical-use failure rate of 4-7% per year 3 is substantially higher than LARC methods. The popularity of pills reflects historical prescribing patterns, not optimal effectiveness.
STI Protection Consideration
All patients must be counseled that hormonal contraceptives and IUDs do not protect against sexually transmitted infections 2. Consistent condom use should be recommended alongside any contraceptive method for STI prevention 2. This is particularly important as condom use often decreases when effective non-barrier methods are initiated 6.
Implementation Strategy
When initiating LARC:
- Implants: Can start anytime; if >5 days after menses, use backup contraception for 7 days 5
- LNG-IUD: Can start anytime; if >7 days after menses, use backup contraception for 7 days 5
- Copper IUD: Can start anytime; no backup contraception needed 5
The evidence strongly supports prioritizing LARC methods to minimize unintended pregnancy rates and their associated morbidity, while maximizing continuation rates and patient satisfaction.